...
首页> 外文期刊>BMJ: British medical journal >NHS to fund treatment for 10 000 patients with MS
【24h】

NHS to fund treatment for 10 000 patients with MS

机译:NHS为治疗患者000 MS

获取原文
获取原文并翻译 | 示例
           

摘要

Patients with multiple sclerosis will now be able to have "disease modifying" drugs under a new government scheme of "risk sharing" for England and Wales, the Department of Health announced this week. Patients who are assessed as likely to benefit from the drugs will be given them until they are deemed to be no longer effective. Simultaneously, the National Institute for Clinical Excellence (NICE) released its "guidance on drugs for multiple sclerosis" which recommended against the use of interferon beta or glatiramer acetate by the NHS on the basis of "clinical and cost effectiveness."
机译:罹患多发性硬化症的病人现在就可以“修改”的新药物英国政府计划的“风险分担”和威尔士,卫生部公布这个星期。从药物会给他们直到中受益他们不再被认为是有效的。同时,国家研究所临床机构(NICE)发布了“指导在多发性硬化症药物”对使用干扰素β或推荐醋酸glatiramer NHS的基础上“临床和成本效益。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号